These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 29885269)

  • 1. Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study.
    Hesselvig JH; Egeberg A; Kofoed K; Gislason G; Dreyer L
    Br J Dermatol; 2018 Nov; 179(5):1095-1101. PubMed ID: 29885269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
    Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
    Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
    Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
    Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study.
    Ahlehoff O; Wu JJ; Raunsø J; Kristensen SL; Khalid U; Kofoed K; Gislason G
    Lupus; 2017 Nov; 26(13):1435-1439. PubMed ID: 28618892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark.
    Petersen MP; Möller S; Bygum A; Voss A; Bliddal M
    Lupus; 2018 Aug; 27(9):1424-1430. PubMed ID: 29788808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Drug Use and Subsequent Diagnosis of Lupus Erythematosus.
    Haugaard JH; Kofoed K; Gislason G; Dreyer L; Egeberg A
    JAMA Dermatol; 2020 Nov; 156(11):1199-1207. PubMed ID: 32876672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
    Grönhagen CM; Fored CM; Granath F; Nyberg F
    Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
    Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
    J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Risk of Autoimmune Diseases other than Systemic Lupus Erythematosus in Cutaneous Lupus Erythematosus-Alone Patients: A 10-Year Nationwide Cohort Study.
    Lin TL; Wu CY; Juan CK; Chang YT; Chen YJ
    Dermatology; 2022; 238(1):92-100. PubMed ID: 34062538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.
    Jarukitsopa S; Hoganson DD; Crowson CS; Sokumbi O; Davis MD; Michet CJ; Matteson EL; Maradit Kremers H; Chowdhary VR
    Arthritis Care Res (Hoboken); 2015 May; 67(6):817-28. PubMed ID: 25369985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: A monocentric study of 149 patients.
    Masseran C; Perray L; Murat de Montai Q; Mathian A; Teboul A; Francès C; Arnaud L; Costedoat-Chalumeau N; Amoura Z; Courvoisier DS; Barbaud A; Chasset F
    J Am Acad Dermatol; 2024 Jun; 90(6):1210-1217. PubMed ID: 38301924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study.
    Shams-Eldin AN; Yafasova A; Faurschou M; Schou M; Sun G; Gislason GH; Torp-Pedersen C; Fosbøl EL; Køber L; Butt JH
    Clin Rheumatol; 2022 Nov; 41(11):3525-3536. PubMed ID: 35907102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Black patients with cutaneous lupus are associated with positive family history of cutaneous lupus and systemic lupus.
    Keum H; Brown LS; Chong BF
    Lupus Sci Med; 2022 Dec; 9(1):. PubMed ID: 36600582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune Diseases in Patients With Cutaneous Lupus Erythematosus.
    Kunzler E; Hynan LS; Chong BF
    JAMA Dermatol; 2018 Jun; 154(6):712-716. PubMed ID: 29801110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The behavior, attitude, and knowledge towards photoprotection in patients with cutaneous/systemic lupus erythematosus: a comparative study with 526 patients and healthy controls.
    Chanprapaph K; Ploydaeng M; Pakornphadungsit K; Mekwilaiphan T; Vachiramon V; Kanokrungsee S
    Photochem Photobiol Sci; 2020 Sep; 19(9):1201-1210. PubMed ID: 32935699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family history of systemic lupus erythematosus and risk of autoimmune disease: Nationwide Cohort Study in Denmark 1977-2013.
    Ulff-Møller CJ; Simonsen J; Kyvik KO; Jacobsen S; Frisch M
    Rheumatology (Oxford); 2017 Jun; 56(6):957-964. PubMed ID: 28339674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer risk in cutaneous lupus erythematosus: a population-based cohort study.
    Singh AG; Crowson CS; Singh S; Davis MD; Maradit-Kremers H; Matteson EL; Chowdhary VR
    Rheumatology (Oxford); 2016 Nov; 55(11):2009-2013. PubMed ID: 27520797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the progression from cutaneous lupus to systemic lupus erythematosus.
    Zhou W; Wu H; Zhao M; Lu Q
    Expert Rev Clin Immunol; 2020 Aug; 16(8):829-837. PubMed ID: 32746644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between oral lesions and disease activity in lupus erythematosus.
    Del Barrio-Díaz P; Reyes-Vivanco C; Cifuentes-Mutinelli M; Manríquez J; Vera-Kellet C
    J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):349-356. PubMed ID: 31566809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus.
    Szepietowski JC; Nilganuwong S; Wozniacka A; Kuhn A; Nyberg F; van Vollenhoven RF; Bengtsson AA; Reich A; de Vries DE; van Hartingsveldt B; Robinson DW; Gordon R; Hsu B
    Arthritis Rheum; 2013 Oct; 65(10):2661-71. PubMed ID: 23896980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.